Nicola Cotugno Selected Research

Nicola Cotugno Research Topics

Disease

12	COVID-19 12/2023 - 11/2020
9	HIV Infections (HIV Infection) 05/2024 - 04/2013
7	Inflammation (Inflammations) 01/2024 - 01/2019
7	Infections 01/2022 - 01/2012
5	Human Influenza (Influenza) 01/2019 - 03/2012
3	Myocarditis (Carditis) 10/2023 - 01/2023
3	Measles 01/2022 - 03/2015
2	Fever (Fevers) 08/2023 - 07/2023
2	Viremia 07/2023 - 01/2019
2	Thrombocytopenia (Thrombopenia) 01/2022 - 01/2019
2	Neuroblastoma 01/2022 - 08/2021
2	Neoplasms (Cancer) 01/2022 - 01/2022
2	Acquired Immunodeficiency Syndrome (AIDS) 01/2019 - 04/2013
2	Chronic Granulomatous Disease 01/2018 - 03/2015
1	Edema (Dropsy) 08/2023
1	Chest Pain (Chest Pains) 08/2023
1	Pulmonary Aspergillosis 07/2023
1	Pericarditis 01/2023
1	Pericardial Effusion 01/2023
1	Skin Diseases (Skin Disease) 01/2023
1	Cryptosporidiosis 01/2023
1	Down Syndrome (Down's Syndrome) 01/2022
1	Dermatitis 01/2022
1	Vasculitis (Vasculitides) 01/2022
1	Colitis 01/2022
1	Reinfection 01/2022
1	Eosinophilia 01/2022
1	Cytokine Release Syndrome 11/2020
1	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 11/2020
1	Virus Diseases (Viral Diseases) 07/2019
1	Dysbiosis 01/2019
1	Opportunistic Infections (Opportunistic Infection) 01/2019
1	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2019
1	Tetanus 01/2019
1	Failure to Thrive 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2019
1	Agammaglobulinemia (Hypogammaglobulinemia) 01/2019
1	Coinfection 01/2019
1	Vaccine-Preventable Diseases 09/2016
1	Primary Immunodeficiency Diseases 03/2015
1	Pneumonia (Pneumonitis) 06/2013
1	Respiratory Insufficiency (Respiratory Failure) 06/2013
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 04/2013
1	Kidney Diseases (Kidney Disease) 01/2012

Drug/Important Bio-Agent (IBA)

13	VaccinesIBA 08/2023 - 03/2012
4	Messenger RNA (mRNA)IBA 12/2023 - 01/2022
4	AntigensIBA 12/2023 - 01/2017
3	AntibodiesIBA 12/2023 - 02/2016
3	Proteins (Proteins, Gene)FDA Link 10/2023 - 01/2022
3	BNT162 VaccineIBA 08/2023 - 01/2022
3	EnzymesIBA 08/2023 - 02/2014
2	RNA (Ribonucleic Acid)IBA 01/2024 - 07/2023
2	Biomarkers (Surrogate Marker)IBA 01/2024 - 11/2020
2	CytokinesIBA 01/2024 - 11/2020
2	mRNA VaccinesIBA 12/2023 - 10/2023
2	Notch ReceptorsIBA 01/2023 - 04/2022
2	LigandsIBA 01/2022 - 07/2019
2	Immunoglobulin A (IgA)IBA 01/2022 - 01/2021
2	NectinsIBA 01/2022 - 07/2019
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018 - 03/2015
2	ImmunosorbentsIBA 09/2016 - 02/2014
1	DNA (Deoxyribonucleic Acid)IBA 01/2024
1	COVID-19 VaccinesIBA 08/2023
1	liposomal amphotericin B FDA Link 07/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 07/2023
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 07/2023
1	Caspofungin (Cancidas)FDA Link 07/2023
1	TroponinIBA 01/2023
1	CD40 Ligand (CD40L)IBA 01/2023
1	pro-brain natriuretic peptide (1-76)IBA 01/2023
1	Mechanistic Target of Rapamycin Complex 1IBA 04/2022
1	Monoclonal AntibodiesIBA 01/2022
1	Amino Acids FDA Link 01/2022
1	nutlin 3IBA 01/2022
1	Actin-Related Protein 2-3 Complex (Arp2 3 Complex)IBA 01/2022
1	16S Ribosomal RNAIBA 01/2022
1	Immunoglobulin E (IgE)IBA 01/2022
1	remdesivirIBA 01/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2022
1	NF-kappa B (NF-kB)IBA 08/2021
1	Neutralizing AntibodiesIBA 01/2021
1	InterleukinsIBA 11/2020
1	AutoantibodiesIBA 11/2020
1	Immunoglobulins (Immunoglobulin)IBA 01/2019
1	Immunoglobulin G (IgG)IBA 01/2019
1	Fluorescent Dyes (Fluorescent Probes)IBA 01/2019
1	Interleukin-7 Receptors (Interleukin 7 Receptor)IBA 01/2019
1	Influenza Vaccines (Influenza Vaccine)FDA Link 02/2016
1	Toll-Like Receptor 9IBA 03/2015
1	Ribavirin (Virazole)FDA LinkGeneric 06/2013
1	SteroidsIBA 06/2013
1	Intravenous Immunoglobulins (IVIG)FDA Link 06/2013

Therapy/Procedure

9	Art Therapy 05/2024 - 01/2012
8	Therapeutics 11/2023 - 06/2013
1	Immunotherapy 07/2019
1	Transplantation 09/2016
1	Extracorporeal Membrane Oxygenation 06/2013
1	Highly Active Antiretroviral Therapy (HAART) 04/2013